Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Aug 4, 2021 FORM 4
4 Aug 2, 2021 OWNERSHIP DOCUMENT
PRE 14A Aug 2, 2021 PRE 14A
SC 13D/A Aug 2, 2021 SC 13D/A
8-K Aug 2, 2021 8-K
8-K Jul 13, 2021 8-K
4 Jun 15, 2021 FORM 4
3 Jun 10, 2021 FORM 3
10-K Jun 1, 2021 10-K
8-K Jun 1, 2021 8-K
4/A Mar 31, 2021 FORM 4/A
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
4 Mar 23, 2021 FORM 4
SC 13D/A Mar 8, 2021 SC 13D/A
UPLOAD Feb 18, 2021
CORRESP Feb 17, 2021
SC 13G/A Feb 16, 2021
← Newer Page 18 of 26 · 643 filings Older →